Topics
April 2012 | feature Stories
Novel Optogenetic Therapy May Restore Vision After Retinal Degeneration
Researchers have developed an approach to restore vision using a component of green algae.
Callan Navitsky, Associate Editor
June 26, 2026
Hoya Vision Care, Nidek Renew Global Strategic Partnership to Advance Integrated Vision Care
June 24, 2026
Kalaris to Present Phase 1a Data on VEGF/HSPG Biologic at ASRS 2026
Ollin Biosciences Raises $330 Million to Advance Phase 3 Development of VEGF/Ang2 bispecific Antibody
June 23, 2026
Oculgen Announces First US Patient Enrolled in STAT Trial of OCUL101 for Wet AMD
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
